GOLDMAN SACHS GROUP INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$6,834,033
-5.8%
4,556,022
-0.1%
0.00%0.0%
Q2 2023$7,252,257
+121.8%
4,561,168
+0.1%
0.00%0.0%
Q1 2023$3,269,665
+2670.9%
4,557,659
+3562.1%
0.00%
Q3 2022$118,000
-54.1%
124,455
-41.9%
0.00%
Q2 2022$257,000
-25.7%
214,174
-19.0%
0.00%
Q1 2022$346,000
-59.5%
264,273
-45.5%
0.00%
Q4 2021$854,000
-55.5%
484,884
-45.2%
0.00%
Q3 2021$1,920,000
-33.1%
884,703
+7.9%
0.00%
-100.0%
Q2 2021$2,870,000
-79.2%
819,955
-41.4%
0.00%
-66.7%
Q1 2021$13,804,000
-8.2%
1,400,044
+0.9%
0.00%
-25.0%
Q4 2020$15,036,000
+52.3%
1,387,143
+44.7%
0.00%
+33.3%
Q3 2020$9,873,000
-58.5%
958,574
-15.9%
0.00%
-57.1%
Q2 2020$23,797,000
+168.6%
1,139,697
+25.7%
0.01%
+133.3%
Q1 2020$8,860,000
-32.7%
906,878
-20.7%
0.00%0.0%
Q4 2019$13,171,000
+353.4%
1,143,363
+114.5%
0.00%
+200.0%
Q3 2019$2,905,000
-7.0%
532,996
+102.9%
0.00%0.0%
Q2 2019$3,123,000
+389.5%
262,673
+115.9%
0.00%
Q1 2019$638,000
+147.3%
121,684
+48.2%
0.00%
Q4 2018$258,000
+193.2%
82,128
+461.4%
0.00%
Q3 2018$88,000
-97.6%
14,628
-97.7%
0.00%
-100.0%
Q1 2018$3,680,000
+979.2%
634,545
+552.0%
0.00%
Q4 2017$341,000
-18.8%
97,329
-42.1%
0.00%
Q2 2017$420,000
+288.9%
168,032
+351.0%
0.00%
Q4 2016$108,000
-20.0%
37,254
+13.7%
0.00%
Q3 2016$135,000
-36.9%
32,773
-51.5%
0.00%
Q2 2016$214,00067,6240.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders